Your session is about to expire
← Back to Search
Behavioural Intervention
Computerized Cognitive Exercise Training for Multiple Sclerosis
N/A
Waitlist Available
Research Sponsored by Stony Brook University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Definite MS Diagnosis, any subtype
Ages 18-70
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12weeks
Awards & highlights
Study Summary
This trial is testing a new computer-based treatment for cognitive impairment in people with multiple sclerosis, to see if it is better than a control computer-based treatment.
Who is the study for?
Adults aged 18-70 with Multiple Sclerosis (MS) who have some cognitive impairment and can operate a computer may join this trial. They should be stable on their current medications, have no recent MS relapses or steroid treatments, and not suffer from other major neurological or psychiatric conditions that could affect cognition.Check my eligibility
What is being tested?
The study is testing a computerized cognitive exercise program called PACR designed to improve brain function in people with MS. Participants will use the program for 60 hours over 12 weeks, comparing its effectiveness against a control activity using similar time on a provided laptop.See study design
What are the potential side effects?
Since the intervention involves non-invasive computer exercises, there are no direct physical side effects expected from participating in this trial. However, participants might experience eye strain or fatigue from extended screen time.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with multiple sclerosis.
Select...
I am between 18 and 70 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
A composite derived from a standardized battery of neuropsychological tests
Secondary outcome measures
A timed measure based on direct observation of functional performance
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment AExperimental Treatment1 Intervention
plasticity-based, adaptive, computerized cognitive remediation (PACR)
Group II: Treatment BActive Control1 Intervention
Ordinary Computer Games (an "active control condition")
Find a Location
Who is running the clinical trial?
Stony Brook UniversityLead Sponsor
213 Previous Clinical Trials
39,391 Total Patients Enrolled
5 Trials studying Multiple Sclerosis
122 Patients Enrolled for Multiple Sclerosis
National Multiple Sclerosis SocietyOTHER
95 Previous Clinical Trials
9,347 Total Patients Enrolled
93 Trials studying Multiple Sclerosis
8,993 Patients Enrolled for Multiple Sclerosis
National Multiple Sclerosis Society (NMSS)UNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have any serious uncontrolled medical conditions.I do not have a psychiatric condition that affects my participation.You have a problem with drinking alcohol or using other drugs.You have a history of conditions that affect thinking and learning.I have been diagnosed with multiple sclerosis.You have cognitive impairment, as determined by a test score that is significantly lower than average.You scored 37 or higher on the WRAT-3 reading test.I am between 18 and 70 years old.You have used Posit Science computer-based training before.I haven't had a relapse or taken steroids in the last month.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment A
- Group 2: Treatment B
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there still room for people to participate in this research project?
"Clinicaltrials.gov indicates that this particular research project is no longer enrolling patients, with the original posting on September 1st 2013 and last update occurring on November 18th 2015. Nevertheless, 555 other medical trials are currently seeking participants to join their studies."
Answered by AI
Are participants below the age of twenty eligible for this research?
"To be included in this medical trial, individuals must fall between the ages of 18 and 70. Those under 18 have access to 44 different clinical trials while those over 65 can participate in 395 separate studies."
Answered by AI
Could I gain admittance to participate in this research?
"This multiple sclerosis clinical trial is seeking 136 volunteers, aged 18 to 70, who exhibit probable cognitive impairment (as defined by a score ≤ 1 SD below the mean of normative data on the SDMT), have no recent relapses or steroid treatment history and must maintain their current medications for 3 months. Additionally, they should be able to read at least 37+ on WRAT-3 and agree to borrow laptop if necessary."
Answered by AI
Who else is applying?
What state do they live in?
New York
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger